Depomed Inc (NASDAQ:DEPO)

20.86
Delayed Data
As of May 29
 +0.16 / +0.77%
Today’s Change
9.85
Today|||52-Week Range
28.16
+29.48%
Year-to-Date

Today’s Trading

Previous close20.70
Today’s open20.66
Day’s range20.65 - 21.33
Volume1,588,761
Average volume (3 months)1,746,846
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+173.33%
Earnings growth (this year)-15.38%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+190.87%
P/E ratio13.5
Price/Sales2.41
Price/Book3.39

Competitors

 Today’s
change
Today’s
% change
VBLTVascular Biogenics L...+0.67+9.08%
NEPTNeptune Technologies...+0.02+1.83%
TEVATeva Pharmaceutical-0.74-1.22%
Data as of 4:02pm ET, 05/29/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.00
Annual revenue (last year)$390.4M
Annual profit (last year)$131.8M
Net profit margin33.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers